Frequency of and rationales for the combined use of electroconvulsive therapy and antiepileptic drugs in Austria and the literature

References

• Aarre TF, Bugge P. ECT for patients taking lamotrigine. Eur Psychiatry 2002; 17(Suppl 1)135
   Google Scholar
• Abrams R, Volavka J, Schrift M. Brief pulse ECT in melancholia. EEG and clinical effects. J Nerv Ment Dis 1992; 180: 555–557
   Google Scholar
• Adli M, Bschor T, Canata B, Dopfmer S, Bauer M. Lithium in the treatment of acute depression. Fortschr Neurol Psychiatr 1998; 66: 435–441
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. The practice of ECT: Recommendations for treatment, training and privileging2nd ed. 2001. Washington, DC: American Psychiatric Publishers.
   Google Scholar
• Andersen FA, Arsland D, Holst-Larsen H. Effects of combined methohexitone-remifentanil anaesthesia in electroconvulsive therapy. Acta Anaesthesiol Scand 2001; 45: 830–833
   PubMedGoogle Scholar
• Avramov MN, Husain MM, White PF. The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesth Analg 1995; 81: 596–602
   PubMed Web of Science ®Google Scholar
• Bachmann RF, Schloesser RJ, Gould TD, Manji HK. Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics. Mol Neurobiol 2005; 32: 173–202
   PubMed Web of Science ®Google Scholar
• Barbee JG, Jamhour NJ. Lamotrigine as an augmentation agent in treatment-resistant depression. J Clin Psychiatry 2002; 63: 737–741
   PubMed Web of Science ®Google Scholar
• Barbosa L, Berk M, Vorster M. A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes. J Clin Psychiatry 2003; 64: 403–407
   PubMed Web of Science ®Google Scholar
• Basselin M, Chang L, Rapoport SI. Chronic lithium chloride administration to rats elevates glucose metabolism in wide areas of brain, while potentiating negative effects on metabolism of dopamine D2-like receptor stimulation. Psychopharmacology 2006; 187: 303–311
   PubMedGoogle Scholar
• Bhat SK, Acosta D, Swartz CM. Postictal asystole during ECT. J ECT 2002; 18: 103–106
   PubMedGoogle Scholar
• Black DW, Winokur G, Nasrallah A. Treatment of mania: a naturalistic study of electroconvulsive therapy versus lithium in 438 patients. J Clin Psychiatry 1987; 48: 132–139
   PubMed Web of Science ®Google Scholar
• Bocchio-Chiavetto L, Zanardini R, Bortolomasi M, Abate M, Segala M, Giacopuzzi M, et al. Electroconvulsive therapy (ECT) increases serum brain derived neurotrophic factor (BDNF) in drug resistant depressed patients. Eur Neuropsychopharmacol 2006; 16: 620–624
   PubMed Web of Science ®Google Scholar
• Bourgon LN, Kellner CH. Relapse of depression after ECT: a review. J ECT 2000; 16: 19–31
   PubMed Web of Science ®Google Scholar
• Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. J Am Med Assoc 1994; 271: 918–924
   PubMed Web of Science ®Google Scholar
• Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 2000; 57: 481–489
   PubMed Web of Science ®Google Scholar
• Bowden, CL, Calabrese, JR, Sachs, G, Lakshmi, N, Yatham, LN, Asghar, SA, , et al. Lamictal 606 Study Group. 2003. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry, 60:392–400.
   PubMedGoogle Scholar
• Brown EB, McElroy SL, Keck PE, Jr, Deldar A, Adams DH, Tohen M, et al. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. J Clin Psychiatry 2006; 67: 1025–1033
   PubMed Web of Science ®Google Scholar
• Bromet EJ, Finch SJ, Carlson GA, Fochtmann L, Mojtabai R, Craig TJ, et al. Time to remission and relapse after the first hospital admission in severe bipolar disorder. Soc Psychiatry Psychiatr Epidemiol 2005; 40: 106–113
   PubMed Web of Science ®Google Scholar
• Cantor C. Carbamazepine and ECT: a paradoxical combination. J Clin Psychiatry 1986; 47: 276–277
   PubMedGoogle Scholar
• Challiol V. L′azione del luminal nella crisi dell‘elettroschock. Riv Sper Freniat Med Legale 1940; 664: 635–648
   Google Scholar
• Craig TJ, Grossman S, Mojtabai R, Gibson PJ, Lavelle J, Carlson GA, et al. Medication use patterns and 2-year outcome in first-admission bipolar disorder with psychotic features. Bipolar Disord 2004; 6: 406–415
   PubMed Web of Science ®Google Scholar
• Devanand DP, Sackeim HA, Decina P, Prudic J. The development of mania and organic euphoria during ECT. J Clin Psychiatry 1988; 49: 69–71
   PubMedGoogle Scholar
• Di Daniel E, Cheng L, Maycox PR, Mudge AW. The common inositol-reversible effect of mood stabilizers on neurons does not involve GSK3 inhibition, myo-inositol-1-phosphate synthase or the sodium-dependent myo-inositol transporters. Mol Cell Neurosci 2006; 32: 27–36
   PubMed Web of Science ®Google Scholar
• Dixon JF, Hokin LE. Lithium acutely inhibits and chronically upregulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex. Proc Natl Acad Sci USA 1998; 95: 8363–8368
   PubMed Web of Science ®Google Scholar
• Dolenc TJ, Rasmussen KG. The safety of electroconvulsive therapy and lithium in combination: a case series and review of the literature. J ECT 2005; 21: 165–170
   PubMed Web of Science ®Google Scholar
• Fink M. Convulsive therapy: a review of the first 55 years. J Affect Disord 2001; 63: 1–15
   PubMed Web of Science ®Google Scholar
• Frederikse M, Petrides G, Kellner C. Continuation and maintenance electroconvulsive therapy for the treatment of depressive illness: a response to the National Institute for Clinical Excellence report. J ECT 2006; 22: 13–17
   PubMedGoogle Scholar
• Freeman TW, Clothier JL, Pazzaglia P, Lesem MD, Swann AC. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 1992; 149: 108–111
   PubMed Web of Science ®Google Scholar
• Gagné GG, Furman MJ, Carpenter LL, Price LH. Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. Am J Psychiatry 2000; 157: 1960–1965
   PubMed Web of Science ®Google Scholar
• Gaillard WD, Zeffiro T, Fazilat S, DeCarli C, Theodore WH. Effect of valproate on cerebral metabolism and blood flow: an 18F-2-deoxyglucose and 15O water positron emission tomography study. Epilepsia 1996; 37: 515–521
   PubMed Web of Science ®Google Scholar
• Geddes J. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 2003; 361: 799–808
   PubMed Web of Science ®Google Scholar
• Gelenberg AJ, Pies R. Matching the bipolar patient and the mood stabilizer. Ann Clin Psychiatry 2003; 15: 203–216
   PubMedGoogle Scholar
• Gitlin M. Treatment-resistant bipolar disorder. Mol Psychiatry 2006; 11: 227–240
   PubMed Web of Science ®Google Scholar
• Goldberg JF, Harrow M. Consistency of remission and outcome in bipolar and unipolar mood disorders: a 10-year prospective follow-up. J Affect Disord 2004; 81: 123–131
   PubMed Web of Science ®Google Scholar
• Goodwin GM, Bowden CL, Calabrese JR, Grunze H, Kasper S, White R, et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 2004; 65: 432–441
   PubMed Web of Science ®Google Scholar
• Grimes CA, Jope RS. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 2001; 65: 391–426
   PubMed Web of Science ®Google Scholar
• Grunhaus L, Dolberg O, Lustig M. Relapse and recurrence following a course of ECT: reasons for concern and strategies for further investigation. J Psychiatr Res 1995; 29: 165–172
   PubMedGoogle Scholar
• Grunze H, Kasper S, Goodwin G, Bowden C, Baldwin D, Licht R, et al. World Federation of Societies of Biological Psychiatry Task Force on Treatment Guidelines for Bipolar Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression. World J Biol Psychiatry 2002; 3: 115–124
   PubMedGoogle Scholar
• Grunze H, Kasper S, Goodwin G, Bowden C, Baldwin D, Licht RW, et al. WFSBP Task Force on Treatment Guidelines for Bipolar Disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of mania. World J Biol Psychiatry 2003; 4: 5–13
   PubMed Web of Science ®Google Scholar
• Grunze H, Kasper S, Goodwin G, Bowden C, Möller HJ. WFSBP Task Force on Treatment Guidelines for Bipolar Disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment. World J Biol Psychiatry 2004; 5: 120–135
   PubMed Web of Science ®Google Scholar
• Gur E, Dremencov E, Garcia F, Van de Kar LD, Lerer B, Newman ME. Functional effects of chronic electroconvulsive shock on serotonergic 5-HT(1A) and 5-HT(1B) receptor activity in rat hippocampus and hypothalamus. Brain Res 2002; 952: 52–60
   PubMedGoogle Scholar
• Hantouche EG, Akiskal HS, Lancrenon S, Chatenet-Duchene L. Mood stabilizer augmentation in apparently “unipolar” MDD: predictors of response in the naturalistic French national EPIDEP study. J Affect Disord 2005; 84: 243–249
   PubMed Web of Science ®Google Scholar
• Hartong, EG, Moleman, P, Hoogduin, CA, Broekman, TG, Nolen, WA; LitCar Group. 2003. Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients. J Clin Psychiatry, 64:144–151.
   PubMed Web of Science ®Google Scholar
• Holt WL, Jr, Borkowski W. Drug-modified electric shock therapy; clinical response to partial seizures facilitated by the anticonvulsant drugs, diphenylhydantoin and mephenesin, alone and in combination. Psychiatr Q 1951; 25: 581–588
   PubMedGoogle Scholar
• Ishihara K, Sasa M. Mechanism underlying the therapeutic effects of electroconvulsive therapy (ECT) on depression. Jpn J Pharmacol 1999; 80: 185–189
   PubMedGoogle Scholar
• Janicak PG, Davis JM, Gibbons RD, Ericksen S, Chang S, Gallagher Pl. Efficacy of ECT: a meta-analysis. Am J Psychiatry 1985; 142: 297–302
   PubMed Web of Science ®Google Scholar
• Joo EY, Hong SB, Tae WS, Han SJ, Seo DW, Lee KH, et al. Effect of lamotrigine on cerebral blood flow in patients with idiopathic generalised epilepsy. Eur J Nucl Med Mol Imaging 2006; 33: 724–729
   PubMedGoogle Scholar
• Joseph TC, Ronald SD. Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 2003; 38: 157–160
   PubMedGoogle Scholar
• Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59: 530–537
   PubMed Web of Science ®Google Scholar
• Judd LL, Akiskal HS, Schettler PJ, Coryell W, Endicott J, Maser JD, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003; 60: 261–269
   PubMed Web of Science ®Google Scholar
• Kahn DA, Sachs GS, Printz DJ, Carpenter D, Docherty JP, Ross R. Medication treatment of bipolar disorder 2000: a summary of the expert consensus guidelines. J Psychiatr Pract 2000; 6: 197–211
   PubMedGoogle Scholar
• Kalin NH. Management of the depressive component of bipolar disorder. Depress Anxiety 1996–1997; 4: 190–198
   PubMedGoogle Scholar
• Kaufman KR, Finstead BA, Kaufman ER. Status epilepticus following electroconvulsive therapy. Mt Sinai J Med 1986; 53: 119–122
   PubMedGoogle Scholar
• Kellner CH. ECT and manic switching: bipolar IV disorder. J ECT 1999; 15: 243–244
   PubMed Web of Science ®Google Scholar
• Khalid N, Atkins M, Kirov G. The effects of etomidate on seizure duration and electrical stimulus dose in seizure-resistant patients during electroconvulsive therapy. J ECT 2006; 22: 184–188
   PubMed Web of Science ®Google Scholar
• Kho KH, van Vreeswijk MF, Simpson S, Zwinderman AH. A meta-analysis of electroconvulsive therapy efficacy in depression. J ECT 2003; 19: 139–147
   PubMed Web of Science ®Google Scholar
• Klapheke MM. Clozapine, ECT, and schizoaffective disorder, bipolar type. Convuls Ther 1991; 7: 36–39
   PubMedGoogle Scholar
• Krystal JH, Sanacora G, Blumberg H, Anand A, Charney DS, Marek G, et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry 2002; 7(Suppl 1)S71–80
   PubMedGoogle Scholar
• Landmark CJ. Targets for antiepileptic drugs in the synapse. Med Sci Monit 2007; 13: 1–7
   Google Scholar
• Layne EM, Young JL, Votolato NA, Nicholas A, Miller KM, Martin BS. Effect of concurrent lamotrigine in patients receiving electroconvulsive therapy. J ECT 2005; 21: 60
   Google Scholar
• Leiderman DB, Balish M, Bromfield EB, Theodore WH. Effect of valproate on human cerebral glucose metabolism. Epilepsia 1991; 32: 417–422
   PubMed Web of Science ®Google Scholar
• Li X, Bijur GN, Jope RS. Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection. Bipolar Disord 2002; 4: 137–144
   PubMed Web of Science ®Google Scholar
• Lim PZ, Tunis SL, Edell WS, Jensik SE, Tohen M. Medication prescribing patterns for patients with bipolar I disorder in hospital settings: adherence to published practice guidelines. Bipolar Disord 2001; 3: 165–173
   PubMed Web of Science ®Google Scholar
• Lunde ME, Lee EK, Rasmussen KG. Electroconvulsive therapy in patients with epilepsy. Epilepsy Behav 2006; 9: 355–359
   PubMed Web of Science ®Google Scholar
• Macritchie KA, Geddes JR, Scott J, Haslam DR, Goodwin GM. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cochrane Database Syst Rev 2001; 3: CD003196
   Google Scholar
• Macritchie KA, Geddes JR, Scott J, Haslam D, de Lima M, Goodwin G. Valproate for acute mood episodes in bipolar disorder. Cochrane Database Syst Rev 2003; 1: CD004052
   PubMedGoogle Scholar
• Mai L, Jope RS, Li X. BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents. J Neurochem 2002; 82: 75–83
   PubMed Web of Science ®Google Scholar
• Manning JS, Haykal RF, Connor PD, Cunningham PD, Jackson WC, Long S. Sustained remission with lamotrigine augmentation or monotherapy in female resistant depressives with mixed cyclothymic-dysthymic temperament. J Affect Disord 2005; 84: 259–266
   PubMedGoogle Scholar
• Marchetti RL, Fiore LA, Peluso MA, Rigonatti SP. Safety and efficacy of ECT in mental disorders associated with epilepsy: report of three cases. J ECT 2003; 19: 173–176
   PubMedGoogle Scholar
• McCall WV, Reboussin DM, Weiner RD, Sackeim HA. Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects. Arch Gen Psychiatry 2000; 57: 438–444
   PubMed Web of Science ®Google Scholar
• Mukherjee S. Combined ECT and lithium therapy. Convuls Ther 1993; 9: 274–284
   PubMedGoogle Scholar
• Mukherjee S, Sackeim HA, Schnur DB. Electroconvulsive therapy of acute manic episodes: a review of 50 years’ experience. Am J Psychiatry 1994; 151: 169–176
   PubMed Web of Science ®Google Scholar
• Nobler MS, Oquendo MA, Kegeles LS, Malone KM, Campbell CC, Sackeim HA, et al. Decreased regional brain metabolism after ECT. Am J Psychiatry 2001; 158: 305–308
   PubMed Web of Science ®Google Scholar
• Patel AS, Gorst-Unsworth C, Venn RM, Kelley K, Jacob Y. Anesthesia and electroconvulsive therapy: a retrospective study comparing etomidate and propofol. J ECT 2006; 22: 179–183
   PubMedGoogle Scholar
• Pearlman C, Obedian E. ECT-valproic acid interaction. Gen Hosp Psychiatry 1995; 17: 456–457
   PubMedGoogle Scholar
• Penland HR, Ostroff RB. Combined use of lamotrigine and electroconvulsive therapy in bipolar depression: a case series. J ECT 2006; 22: 142–147
   PubMedGoogle Scholar
• Perera TD, Luber B, Nobler MS, Prudic J, Anderson C, Sackeim HA. Seizure expression during electroconvulsive therapy: relationships with clinical outcome and cognitive side effects. Neuropsychopharmacology 2004; 29: 813–825
   PubMed Web of Science ®Google Scholar
• Petrides G, Fink M, Husain MM, Knapp RG, Rush AJ, Mueller M, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT 2001; 17: 244–253
   PubMed Web of Science ®Google Scholar
• Plattner P. Die chirurgischen Komplikationen bei der Elektroschockbehandlung und ihre Vermeidung durch Mesantoin. Monatsschr Psychiatr Neurol 1949; 188: 192–227
   Google Scholar
• Post RM. Role of BDNF in bipolar and unipolar disorder: Clinical and theoretical implications. J Psychiatr Res 2007; 41: 979–990
   PubMed Web of Science ®Google Scholar
• Post RM, Putman F, Contel NR, Goldman B. Electroconvulsive seizure inhibit amygdala kindling: implications for mechanisms of action in affective illness. Epilepsia 1984; 25: 234–239
   PubMedGoogle Scholar
• Post RM, Putnam F, Uhde TW, Weiss SR. Electroconvulsive therapy as an anticonvulsant: implication for its mechanism of action in affective illness. Ann NY Acad Sci 1986; 462: 376–388
   PubMedGoogle Scholar
• Prudic J, Haskett RF, Mulsant B, Malone KM, Pettinati HM, Stephens S, et al. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry 1996; 153: 985–992
   PubMed Web of Science ®Google Scholar
• Pratoomsri W, Yatham LN, Bond DJ, Lam RW, Sohn CH. Oxcarbazepine in the treatment of bipolar disorder: a review. Can J Psychiatry 2006; 51: 540–545
   PubMed Web of Science ®Google Scholar
• Rabheru K, Persad E. A review of continuation and maintenance electroconvulsive therapy. Can J Psychiatry 1997; 42: 476–84
   PubMed Web of Science ®Google Scholar
• Roberts MA, Attah JR. Carbamazepine and ECT. Br J Psychiatry 1988; 153: 418
   PubMedGoogle Scholar
• Roh MS, Kang UG, Shin SY, Lee YH, Jung HY, Juhnn YS, et al. Biphasic changes in the Ser-9 phosphorylation of glycogen synthase kinase-3beta after electroconvulsive shock in the rat brain. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 1–5
   PubMedGoogle Scholar
• Russell JC, Rasmussen KG, O'Connor MK, Copeman CA, Ryan DA, Rummans TA. Long-term maintenance ECT: a retrospective review of efficacy and cognitive outcome. J ECT 2003; 19: 4–9
   PubMedGoogle Scholar
• Sackeim HA. The anticonvulsive hypothesis of mechanism of action of ECT: current status. J ECT 1999; 15: 25–26
   Google Scholar
• Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 2000; 57: 425–434
   PubMed Web of Science ®Google Scholar
• Sanacora G, Mason GF, Rothman DL, Hyder F, Ciarcia JJ, Ostroff RB, et al. Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry 2003; 160: 577–579
   PubMed Web of Science ®Google Scholar
• Sartorius A, Wolf J, Henn FA. Lithium and ECT – concurrent use still demands attention: three case reports. World J Biol Psychiatry 2005; 6: 121–124
   PubMed Web of Science ®Google Scholar
• Schaffer A, Zuker P, Levitt A. Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression. J Affect Disord 2006; 96: 95–99
   PubMedGoogle Scholar
• Sienaert P, Peusken J. Anticonvulsants during electroconvulsive therapy: review and recommendations. J ECT 2007; 23: 120–123
   PubMedGoogle Scholar
• Sienaert P, Bouckaert F, Hagon A, Hagon B, Peusken J. Short seizure in continuation electroconvulsive therapy: an indication for remifentanil anesthesia?. J ECT 2004; 20: 130–131
   PubMedGoogle Scholar
• Sienaert P, Demunter H, Vansteelandt K. Effect of lamotrigine on concurrent electroconvulsive therapy. Eur Neuropsychopharmacol 2006; 16(Suppl 4)348
   Google Scholar
• Sikdar S, Kulhara P, Avasthi A, Singh H. Combined chlorpromazine and electroconvulsive therapy in mania. Br J Psychiatry 1994; 164: 806–810
   PubMedGoogle Scholar
• Small JG. Anticonvulsants in affective disorders. Psychopharmacol Bul 1990; 26: 25–36
   PubMedGoogle Scholar
• Small JG, Klapper MH, Kellams JJ, Miller MJ, Milstein V, Sharpley PH, et al. Electroconvulsive treatment compared with lithium in the management of manic states. Arch Gen Psychiatry 1988; 45: 727–32
   PubMed Web of Science ®Google Scholar
• Southam E, Kirkby D, Higgins GA, Hagan RM. Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats. Eur J Pharmacol 1998; 358: 19–24
   PubMed Web of Science ®Google Scholar
• Stewart JT. Lithium and maintenance ECT. J ECT 2000; 16: 300–301
   PubMedGoogle Scholar
• Strome EM, Clark CM, Zis AP, Doudet DJ. Electroconvulsive shock decreases binding to 5-HT2 receptors in nonhuman primates: an in vivo positron emission tomography study with [18F]setoperone. Biol Psychiatry 2005; 57: 1004–1010
   PubMedGoogle Scholar
• Swoboda E, Conca A, Konig P, Waanders R, Hansen M. Maintenance electroconvulsive therapy in affective and schizoaffective disorder. Neuropsychobiology 2001; 43: 23–28
   PubMed Web of Science ®Google Scholar
• Thornton JE, Mulsant BH, Dealy R, Reynolds CF 3rd. A retrospective study of maintenance electroconvulsive therapy in a university-based psychiatric practice. Convuls Ther 1990; 6: 121–129
   PubMedGoogle Scholar
• Vaidya NA, Mahableshwarkar AR, Shahid R. Continuation and maintenance ECT in treatment-resistant bipolar disorder. J ECT 2003; 19: 10–16
   PubMed Web of Science ®Google Scholar
• Van den Broeck WW, Huyser J, Koster AM. Richtlijn elektroconvulsiv therapie. Boom, Amsterdam 2000
   Google Scholar
• Vanelle JM, Loo H, Galinowski A, de Carvalho W, Bourdel MC, Brochier P, et al. Maintenance ECT in intractable manic-depressive disorders. Convuls Ther 1994; 10: 195–205
   PubMedGoogle Scholar
• Vishne T, Aronov S, Amiaz R, Etchin A, Grunhaus L. Remifentanil supplementation of propofol during electroconvulsive therapy: effect on seizure duration and cardiovascular stability. J ECT 2005; 21: 235–238
   PubMedGoogle Scholar
• Weisler RH, Hirschfeld R, Cutler AJ, Gazda T, Ketter TA, Keck PE, et al. SPD417 Study Group. Extended-release carbamazepine capsules as monotherapy in bipolar disorder: pooled results from two randomised, double-blind, placebo-controlled trials. CNS Drugs 2006; 20: 219–231
   PubMed Web of Science ®Google Scholar
• Winsberg ME, DeGolia SG, Strong CM, Ketter TA. Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression. J Affect Disord 2001; 67: 207–212
   PubMed Web of Science ®Google Scholar
• Zarate CA, Jr, Tohen M, Baraibar G. Combined valproate or carbamacepine and electroconvulsive therapy. Ann Clin Psychiatry 1997; 9: 19–25
   PubMedGoogle Scholar
• Zwil AS, Pomerantz A. Transient postictal psychosis associated with a course of ECT. Convuls Ther 1997; 13: 32–36
   PubMedGoogle Scholar